Related Experiment Video

Updated: Feb 21, 2026

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

902

Extracorporeal membrane oxygenation for Kawasaki disease: two case reports and the Extracorporeal Life Support

Derek Best1, Johnny Millar1,2, Igor Kornilov3

  • 11 Royal Children's Hospital, Melbourne, Australia.

Perfusion
|October 8, 2017
PubMed

Insights

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) successfully supported two children with severe cardiac complications from Kawasaki disease, including shock syndrome and coronary arteritis. This approach offers critical cardiac support for Kawasaki disease patients facing life-threatening heart issues.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Cardiovascular Surgery

Background:

  • Kawasaki disease, a common childhood illness, can lead to severe cardiac complications.
  • Life-threatening cardiac manifestations, including shock and coronary arteritis, pose significant risks.
  • Effective cardiac support strategies are crucial for managing these severe cases.

Observation:

  • Two pediatric patients with Kawasaki disease experienced critical cardiac events.
  • One patient presented with acute Kawasaki disease shock syndrome.
  • The second patient developed complications from coronary arteritis requiring surgery.

Findings:

  • Successful application of veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) for cardiac support in both patients.
  • VA-ECMO provided essential hemodynamic stabilization and end-organ perfusion.
  • Review of the Extracorporeal Life Support Organization (ELSO) database and literature supports this therapeutic approach.

Implications:

  • VA-ECMO is a viable and effective option for pediatric patients with Kawasaki disease experiencing severe cardiac dysfunction.
  • Early consideration of VA-ECMO may improve outcomes in critical Kawasaki disease cases.
  • Further research into ECMO's role in Kawasaki disease management is warranted.

Keywords:
Kawasaki diseaseextracorporeal membrane oxygenation

More Related Videos

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

13.1K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.4K

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
257
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
262
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K